CureDuchenne Ventures

investment firm

Investments

Number of Investments
Number of Lead Investments
16
4
CureDuchenne Ventures has made 16 investments. Their most recent investment was on Jun 7, 2022, when Code Biotherapeutics, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Jun 7, 2022 Code Biotherapeutics Series A Biotechnology
Dec 22, 2021 Gennao Bio Series A Biotechnology Yes
Aug 5, 2021 Pepgen Series Unknown Biotechnology
Apr 20, 2021 Code Biotherapeutics Seed Biotechnology
Mar 31, 2021 Entrada Therapeutics Series B Biotechnology
Dec 9, 2020 Pepgen Series A Biotechnology
Dec 8, 2020 Edgewise Therapeutics Series C Biopharma
Nov 10, 2020 Mesentech Series Unknown Biotechnology
Apr 23, 2020 Myosana Therapeutics Seed Biotechnology Yes
Nov 13, 2019 Avidity Biosciences Series C Biotechnology
Nov 6, 2019 Shape Therapeutics Series A Biotechnology
Sep 17, 2019 Edgewise Therapeutics Series B Biopharma
Sep 5, 2018 4D Molecular Therapeutics Series B Biotechnology
Feb 27, 2017 Exonics Therapeutics Seed Biopharma Yes
Dec 19, 2016 Trinds Series Unknown Market Research Yes
Feb 3, 2015 Capricor Therapeutics Post-IPO Equity Biotechnology